IndieBio is incredibly excited to announce our fifth class of life science companies. Founders have come to San Francisco from all over the world, including Chile, South Africa, Canada, and across the USA.
These teams are tackling problems in a host of industries such as gene therapy, regenerative medicine, the future of food, and Health IT.
BioAesthetics is regenerating the nipple-areolar complex for the 200,000+ women whom undergo mastectomies every year.
DNALite Therapeutics is developing gene therapy treatments for the gastrointestinal tract. The first lead candidate is for colon cancer, which is the second deadliest cancer in the U.S.
Finless Foods is producing real fish meat in vitro to feed 8B+ people in 2020. Their fish is free from the mercury, plastic, and hormones that come with all aquaculture and factory fish.
Health Linkages is the Data Provenance Company. Health Linkages uses a combination of blockchain and big data to enable healthcare and life science institutions to trust, protect and share their data.
QuantumCyte is enabling a deeper understanding of the immune system and cancer biology by enabling next-gen single cell analysis. Their technology has unprecedented ability to analyze large numbers of cells at industry leading resolution.
Pheronym is creating an all natural highly effective insect control for agriculture. By leveraging pheromone spray they double nematode’s effectiveness as an organic insecticide to rival chemicals, without any of the negative health or environmental impact.
Prellis is creating living tissues and organs for pharmaceutical testing and organ transplant. Prellis instantaneously prints high resolution tissue scaffolds that grow into functioning human organs.
Proteorex is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. Their platform can rapidly and cost-effectively unlock previously undruggable targets and has produced multiple partnered compounds.
Stelvio is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma. The resistance of high-grade glioma to conventional cytotoxic drugs has prompted our development of a novel approach to therapy, including differentiating glioma stem cells to less tumorigenic cell fates.
Sugarlogix is creating sugars with functional benefits for healthier foods. Their functional sugars enhance the immune system, promote gut health, and reduce inflammation without compromising taste.
NotCo is combining AI with food-science to craft cutting-edge plant-based foods that deliver unprecedented experiences: Greek Yogurt, Milk, Cheese, Mayo all tasting like the real thing (and even better).
UBA cleans industrial wastewater from coal, gold, and platinum mines with an organic bioremediation system. Their first system is operating on a large coal mine in South Africa.
IndieBio is the world’s largest life sciences accelerator, having funded 67 biotech startups since starting in March 2015. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, and raising follow-on investment.
With a focus on biology as a technology, IndieBio companies solve problems in a huge range of industries such as the future of food, biopharma and healthcare, agtech, regenerative medicine, neurotech, biomaterials, and more. Notable alum include Memphis Meats, Koniku, SyntheX Therapeutics, Catalog, Ava Winery, and Qidni Labs.
View Original Article: https://medium.com/indiebio-sf/announcing-indiebios-5th-class-ad4f245ff420